{"id":459961,"date":"2023-05-07T23:13:18","date_gmt":"2023-05-08T06:13:18","guid":{"rendered":"https:\/\/nai500.com\/?p=459961"},"modified":"2023-05-07T23:13:18","modified_gmt":"2023-05-08T06:13:18","slug":"%e5%b7%b4%e8%8f%b2%e7%89%b9%e9%80%89%e8%82%a1%e7%9a%84%e4%b8%89%e5%a4%a7%e6%a0%87%e5%87%86-%e8%bf%99%e5%8f%aa%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e8%82%a1%e7%a5%a8","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2023\/05\/%e5%b7%b4%e8%8f%b2%e7%89%b9%e9%80%89%e8%82%a1%e7%9a%84%e4%b8%89%e5%a4%a7%e6%a0%87%e5%87%86-%e8%bf%99%e5%8f%aa%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e8%82%a1%e7%a5%a8\/","title":{"rendered":"\u5df4\u83f2\u7279\u9009\u80a1\u7684\u4e09\u5927\u6807\u51c6\uff0c\u8fd9\u53ea\u751f\u7269\u5236\u836f\u80a1\u7968\u5168\u90fd\u6ee1\u8db3"},"content":{"rendered":"<p>\u4f2f\u514b\u5e0c\u5c14\u54c8\u6492\u97e6Berkshire Hathaway\uff08NYSE:BRK.A\uff09\uff08NYSE:BRK.B\uff09\u7684\u9996\u5e2d\u6267\u884c\u5b98\u5df4\u83f2\u7279\u7279\u522b\u559c\u6b22\u6bd4\u55bb\u3002\u5173\u4e8e\u9009\u80a1\u6807\u51c6\uff0c\u5df4\u83f2\u7279\u8ba4\u4e3a\u597d\u516c\u53f8\u7684\u7279\u5f81\u662f\u62e5\u6709\u5f88\u6b3e\u4e14\u6301\u4e45\uff0c\u80fd\u591f\u4fdd\u62a4\u7ecf\u6d4e\u57ce\u5821\u7684\u62a4\u57ce\u6cb3\uff0c\u540c\u65f6\u62e5\u6709\u4e00\u4f4d\u8bda\u5b9e\u7684\u4e3b\u4eba\u638c\u63a7\u5927\u5c40\u3002<\/p>\n<p>\u5982\u679c\u7528\u66f4\u52a0\u4e13\u4e1a\u7684\u8bcd\u8bed\u6765\u8868\u8ff0\uff0c\u597d\u80a1\u7968\u7ade\u4e89\u6709\u9650\uff0c\u7ba1\u7406\u5c42\u4f18\u79c0\uff0c\u540c\u65f6\u62e5\u6709\u957f\u671f\u53ef\u6301\u7eed\u7684\u76c8\u5229\u3002<\/p>\n<p>\u4e0d\u8fc7\uff0c\u8fd9\u6837\u7684\u80a1\u7968\u5e76\u4e0d\u9650\u4e8e\u4f2f\u514b\u5e0c\u5c14\u54c8\u6492\u97e6\u7684\u6295\u8d44\u7ec4\u5408\u3002\u65e0\u8bba\u662f\u5df4\u83f2\u7279\u8fd8\u662f\u4ed6\u7684\u9009\u80a1\u52a9\u624bTodd Combs\u548cTed Weschler\uff0c\u4ed6\u4eec\u5bf9\u4e8e\u98ce\u9669\u90fd\u6781\u7aef\u538c\u6076\uff0c\u56e0\u6b64\u6709\u4e9b\u521b\u65b0\u5bfc\u5411\u7684\u516c\u53f8\uff0c\u5373\u4f7f\u5b83\u4eec\u4e5f\u5728\u7a33\u6b65\u5efa\u7acb\u81ea\u5df1\u7684\u7ade\u4e89\u62a4\u57ce\u6cb3\u4e14\u5728\u7cbe\u82f1\u7ea7\u7ba1\u7406\u56e2\u961f\u7684\u9886\u5bfc\u4e4b\u4e0b\uff0c\u5f80\u5f80\u4e5f\u96be\u5165\u4ed6\u4eec\u7684\u201c\u6cd5\u773c\u201d\u3002<\/p>\n<p>\u751f\u7269\u5236\u836f\u80a1\u7968\u5c31\u662f\u5176\u4e2d\u6700\u597d\u7684\u4f8b\u5b50\u3002\u8fd9\u4e2a\u9886\u57df\u7684\u7ade\u4e89\u6781\u4e3a\u6fc0\u70c8\uff0c\u800c\u4e14\u6781\u6613\u53d7\u4e13\u5229\u95ee\u9898\u7684\u5f71\u54cd\uff0c\u56e0\u6b64\u751f\u7269\u5236\u836f\u80a1\u7968\u5f88\u96be\u5728\u4f2f\u514b\u5e0c\u5c14\u54c8\u6492\u97e6\u7684\u6295\u8d44\u7ec4\u5408\u4e2d\u957f\u671f\u7acb\u8db3\u3002\u5f3a\u751fJohnson &amp; Johnson\uff08NYSE:JNJ\uff09\u662f\u4e00\u4e2a\u4f8b\u5916\uff0c\u4f46\u8fd9\u5f88\u5927\u7a0b\u5ea6\u4e0a\u5f97\u76ca\u4e8e\u8be5\u516c\u53f8AAA\u7ea7\u7684\u8d44\u4ea7\u8d1f\u503a\u8868\u4ee5\u53ca61\u5e74\u7684\u80a1\u606f\u589e\u957f\u53f2\u3002<\/p>\n<p>\u4e0d\u8fc7\uff0c\u4e0b\u9762\u6211\u4eec\u8981\u8bf4\u7684\u8fd9\u53ea\u7f55\u89c1\u75c5\u80a1\u7968\u6ee1\u8db3\u5df4\u83f2\u7279\u9009\u80a1\u7684\u4e09\u5927\u6807\u51c6\u3002<\/p>\n<h2>\u798f\u6cf0\u5236\u836f\uff1a\u7ade\u4e89\u6709\u9650\uff0c\u6df1\u5ea6\u4ef7\u503c\u4ee5\u53ca\u4e00\u6d41\u7684\u7ba1\u7406\u5c42<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=VRTX\">\u798f\u6cf0\u5236\u836fVertex Pharmaceuticals\uff08NASDAQ:VRTX\uff09<\/a>\u501f\u52a9\u5b83\u5728\u96be\u6cbb\u6027\u80ba\u75c5\u56ca\u6027\u7ea4\u7ef4\u5316\uff08CF\uff09\u6cbb\u7597\u5e02\u573a\u7684\u4e3b\u5bfc\u5730\u4f4d\u5efa\u7acb\u4e86\u4e00\u4e2a\u5f3a\u5927\u7684\u7ade\u4e89\u62a4\u57ce\u6cb3\uff0c\u76ee\u524d\u8be5\u516c\u53f8\u5df2\u83b7\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7ba1\u5c40\uff08FDA\uff09\u6279\u51c6\u76844\u6b3e\u836f\u7269\u2014\u2014Kalydeco, Orkambi, Symdeko\u548cTrikafta\u2014\u2014\u8986\u76d6\u4e86\u5168\u7403\u56ca\u6027\u7ea4\u7ef4\u5316\u4eba\u53e3\u7684\u5927\u7ea690%\u3002\u4e0e\u6b64\u540c\u65f6\uff0c\u7c7b\u4f3c\u827e\u4f2f\u7ef4AbbVie\uff08NYSE:ABBV\uff09\u3001\u8bfa\u534eNovartis\uff08NYSE:NVS\uff09\u4ee5\u53ca\u5409\u5229\u5fb7\u79d1\u5b66Gilead Sciences\uff08NASDAQ:GILD\uff09\u7b49\u8fd9\u4e9b\u5236\u836f\u5de8\u5934\u5728\u8fd9\u4e00\u9886\u57df\u5374\u9c9c\u6709\u8fdb\u5c55\u3002<\/p>\n<p>\u798f\u6cf0\u5236\u836f\u5728\u56ca\u6027\u7ea4\u7ef4\u5316\u9886\u57df\u7684\u5730\u4f4d\u4e5f\u4e3a\u5b83\u5e26\u6765\u4e86\u5927\u91cf\u7684\u73b0\u91d1\uff0c\u8be5\u516c\u53f8\u622a\u81f32023\u5e74\u4e00\u5b63\u5ea6\u672b\u7684\u73b0\u91d1\u53ca\u73b0\u91d1\u7b49\u4ef7\u7269\u9ad8\u8fbe115\u4ebf\u7f8e\u5143\u3002\u4e0d\u8fc7\uff0c\u798f\u6cf0\u5236\u836f\u5e76\u6ca1\u6709\u6b62\u6b65\u4e8e\u6b64\uff0c\u800c\u662f\u7528\u8fd9\u4e9b\u8d44\u6e90\u7ee7\u7eed\u5f00\u53d1\u8bf8\u5982\u57fa\u56e0\u7ec4\u548c\u5206\u6790\u7597\u6cd5\u7b49\u5c16\u7aef\u9886\u57df\uff0c\u6bd4\u5982\u6700\u8fd1\u8be5\u516c\u53f8\u8054\u624bCRISPR Therapeutics AG\uff08NASDAQ:CRSP\uff09\u5411FDA\u63d0\u4ea4\u4e86\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5exa-cel\u7684\u4e0a\u5e02\u7533\u8bf7\u3002<\/p>\n<p>\u8fd9\u4e00\u5207\u6210\u5c31\u7684\u53d6\u5f97\u79bb\u4e0d\u4e86\u798f\u6cf0\u5236\u836f\u7684\u9886\u5bfc\u5c42\u4ee5\u53ca\u5b83\u7684\u9996\u5e2d\u6267\u884c\u5b98Reshma Kewalramani\u3002\u5728Kewalramani\u7684\u5f15\u5bfc\u4e4b\u4e0b\uff0c\u8be5\u751f\u7269\u79d1\u6280\u516c\u53f8\u5c06Trikafta\u53d8\u6210\u4e86\u4e00\u6b3e\u8d85\u7ea7\u91cd\u8981\u4ea7\u54c1\uff0c\u8054\u624bCRISPR\u5b8c\u6210\u4e86exa-cel\u4e00\u7cfb\u5217\u590d\u6742\u7684\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u79ef\u7d2f\u4e86\u5927\u91cf\u7684\u73b0\u91d1\uff0c\u5e76\u4e14\u8fbe\u6210\u4e86\u591a\u4e2a\u9ad8\u4ef7\u503c\u7684\u5546\u4e1a\u5f00\u53d1\u534f\u8bae\uff08\u6bd4\u5982\u8bf4\u6700\u8fd1\u5bf9ViaCyte\u7684\u6536\u8d2d\uff09\u3002<\/p>\n<h2>\u8fd9\u53ea\u7c7b\u5df4\u83f2\u7279\u80a1\u7968\u503c\u5f97\u4e70\u5165\u5417\uff1f<\/h2>\n<p>\u5c3d\u7ba1\u798f\u6cf0\u5236\u836f\u7684\u80a1\u4ef72023\u5e74\u5df2\u7ecf\u5927\u6da820%\uff0c\u8dd1\u8d62\u5e02\u573a\uff0c\u4f46\u672a\u6765\u5927\u6982\u7387\u8fd8\u6709\u7ee7\u7eed\u4e0a\u6da8\u7684\u7a7a\u95f4\u3002\u81f3\u4e8e\u7406\u7531\uff0c\u9664\u4e86\u5bf9\u7ecf\u6d4e\u4e0d\u654f\u611f\u7684\u5546\u4e1a\u6a21\u5f0f\uff0c\u4ef7\u503c\u521b\u9020\u5728\u7814\u836f\u7269\u7ba1\u7ebf\u4ee5\u53ca\u7a33\u5065\u7684\u8d22\u52a1\u5916\uff0c\u53e6\u4e00\u4e2a\u5173\u952e\u7684\u8981\u7d20\u662f\u4e0d\u65ad\u589e\u957f\u7684\u73b0\u91d1\u3002\u6709\u4e86\u5145\u88d5\u7684\u73b0\u91d1\uff0c\u798f\u6cf0\u5236\u836f\u5728\u8ffd\u6c42\u4ef7\u503c\u521b\u9020\u673a\u4f1a\u65b9\u9762\u5c31\u6709\u4e86\u66f4\u5927\u7684\u7075\u6d3b\u6027\u3002<\/p>\n<p><audio style=\"display: none;\" controls=\"controls\"><\/audio><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4f2f\u514b\u5e0c\u5c14\u54c8\u6492\u97e6Berkshire Hathaway\uff08NYSE:BRK.A\uff09\uff08NYSE:BRK.B\uff09\u7684\u9996\u5e2d\u6267\u884c\u5b98 [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":432277,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[455,2167,925,459],"class_list":["post-459961","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-455","tag-2167","tag-925","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/459961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=459961"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/459961\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/432277"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=459961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=459961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=459961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}